GlassScriptPhysician profile
Carolyn I Jacob
NPI 1265498083
$566,295.29
in general payments reported to CMS, 2019-2025
39 companies · $66K in 2025
The $66K reported for 2025 was more than what 97% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135K · 2020: $60K · 2021: $89K · 2022: $95K · 2023: $71K · 2024: $50K · 2025: $66K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $113K · Consulting Fee: $34K · Food and Beverage: $17K · Travel and Lodging: $17K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,785 · Education: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $113,395.00 |
| Consulting Fee | $34,200.22 |
| Food and Beverage | $17,446.47 |
| Travel and Lodging | $17,255.90 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,785.00 |
| Education | $153.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $230,079.78 | 2019-2025 | |
| Galderma Laboratories, L.P. | $182,359.61 | 2019-2025 | Nemluvio, Dysport |
| Allergan, INC. | $51,646.07 | 2019-2022 | |
| Solta Medical, A Division of Bausch Health US, LLC | $42,342.63 | 2019-2025 | Clear+Brilliant, Clear & Brilliant |
| Dermira, INC. | $14,224.30 | 2019-2021 | |
| Revance Therapeutics, INC. | $10,053.73 | 2024-2025 | Daxxify |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $9,415.45 | 2019-2023 | |
| Endo Pharmaceuticals INC. | $8,604.66 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $4,657.18 | 2020-2024 | Sotyktu |
| Galderma Research & Development, LLC | $2,975.00 | 2023 | |
| Merz North America, INC. | $2,066.78 | 2019-2025 | |
| Botanix Sb INC | $1,097.33 | 2025 | Sofdra |
| Pfizer INC. | $794.99 | 2019-2025 | |
| Janssen Biotech, INC. | $705.11 | 2019-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $691.54 | 2019-2025 | Ilumya, Winlevi, Absorica Ld |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $592.17 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $529.30 | 2019-2023 | |
| Lilly USA, LLC | $466.43 | 2019-2025 | Taltz, Ebglyss |
| Regeneron Healthcare Solutions, INC. | $445.02 | 2019-2025 | Dupixent |
| Incyte Corporation | $405.54 | 2021-2025 | Opzelura |
| Ucb, INC. | $334.50 | 2022-2025 | Bimzelx, Cimzia |
| Mayne Pharma Commercial LLC | $278.78 | 2019-2025 | |
| Amgen INC. | $272.44 | 2019-2025 | Otezla, Otezla |
| Almirall LLC | $255.10 | 2019-2025 | Seysara, Klisyri |
| Journey Medical Corporation | $152.13 | 2022-2025 | |
| Epi Health, LLC | $151.73 | 2020-2021 | |
| Leo Pharma INC. | $143.96 | 2019-2025 | Anzupgo |
| Vyne Pharmaceuticals INC. | $127.73 | 2020-2021 | |
| Arcutis Biotherapeutics, INC. | $90.57 | 2023-2025 | Zoryve |
| Encore Dermatology INC. | $74.57 | 2019 | |
| Celgene Corporation | $52.05 | 2019 | |
| Sanofi-Aventis U.S. LLC | $41.87 | 2019 | |
| Organon LLC | $33.08 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.02 | 2025 | Spevigo |
| Verrica Pharmaceuticals INC. | $29.80 | 2025 | Ycanth |
| Biofrontera INC. | $24.62 | 2019 | |
| Dermavant Sciences, INC. | $23.27 | 2023 | Vtama |
| Aclaris Therapeutics, INC. | $14.44 | 2019 | |
| Prugen, INC. Pharmaceuticals | $9.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carolyn Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.